Next Article in Journal
Aplastic Anemia: Immunosuppressive Therapy in 2010
Previous Article in Journal
The Role of Haploinsufficiency of rps14 and p53 Activation in the Molecular Pathogenesis of the 5q- Syndrome
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pediatric Reports
Volume 3
Issue s2
10.4081/pr.2011.s2.e9
pediatrrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Pediatric Reports is published by MDPI from Volume 12 Issue 3 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Severe Congenital Neutropenia, a Genetically Heterogeneous Disease Group With an Increased Risk of AML/MDS

by
Peter Vandenberghe
1,* and
Karolien Beel
1
Center for Human Genetics,Universitaire Ziekenhuizen Leuven,Leuven, Belgium
2
Department of Haematology, Internal Medicine,Universitaire Ziekenhuizen Leuven,Leuven, Belgium
*
Author to whom correspondence should be addressed.
Pediatr. Rep. 2011, 3(s2), e9; https://doi.org/10.4081/pr.2011.s2.e9
Submission received: 4 May 2011 / Accepted: 4 June 2011 / Published: 17 June 2011

Abstract

Over the past decade, enormous progress has been made in the understanding of severe congenital neutropenia (SCN), by identification of several causal gene mutations: in ELANE, GFI1, HAX1, WAS and G3PC3. SCN is a preleukemic condition, independent of the genetic subtype. Acquired CSF3R mutations are specific for SCN and are strongly associated with malignant progression. In this review, we describe the known genetic subtypes of SCN, their molecular basis and clinical presentation and summarize the available evidence on CSF3R mutations and monosomy 7 in malignant conversion.
Keywords: severe congenital neutropenia; AML/MDS risk severe congenital neutropenia; AML/MDS risk

Share and Cite

MDPI and ACS Style

Vandenberghe, P.; Beel, K. Severe Congenital Neutropenia, a Genetically Heterogeneous Disease Group With an Increased Risk of AML/MDS. Pediatr. Rep. 2011, 3, e9. https://doi.org/10.4081/pr.2011.s2.e9

AMA Style

Vandenberghe P, Beel K. Severe Congenital Neutropenia, a Genetically Heterogeneous Disease Group With an Increased Risk of AML/MDS. Pediatric Reports. 2011; 3(s2):e9. https://doi.org/10.4081/pr.2011.s2.e9

Chicago/Turabian Style

Vandenberghe, Peter, and Karolien Beel. 2011. "Severe Congenital Neutropenia, a Genetically Heterogeneous Disease Group With an Increased Risk of AML/MDS" Pediatric Reports 3, no. s2: e9. https://doi.org/10.4081/pr.2011.s2.e9

APA Style

Vandenberghe, P., & Beel, K. (2011). Severe Congenital Neutropenia, a Genetically Heterogeneous Disease Group With an Increased Risk of AML/MDS. Pediatric Reports, 3(s2), e9. https://doi.org/10.4081/pr.2011.s2.e9

Article Metrics

Back to TopTop